Chronic Hepatitis News

Recent study data showed that concomitant chronic hepatitis B and nonalcoholic steatohepatitis were significantly more likely to lead to advanced fibrosis and liver-related outcomes including mortality compared with chronic hepatitis B alone.

The American Association for the Study of Liver Diseases Foundation has granted $3.42 million in research and career development awards to 29 researchers and clinicians to conduct liver disease research and undergo advanced hepatology training.

Harvoni joins other direct-acting antivirals in demonstrating safety and high efficacy in younger pediatric patients with chronic hepatitis C, specifically those aged 3 years to younger than 6 years, according to results published in Hepatology.

With $7 million from the Patient-Centered Outcomes Research Institute, seven opioid treatment programs announced entry into an ongoing study of telemedicine for treatment of hepatitis C.

Intent Solutions announced a partnership with the University of Kentucky in a $15 million federal grant program aimed at eliminating hepatitis C in an eastern Kentucky county that has particularly high rates of chronic infection, according to a press release.

Vibration-controlled transient elastography outperformed aspartate aminotransferase to platelet ratio index and Fibrosis-4 index as a noninvasive biomarker for advanced fibrosis in patients with hepatitis B and HIV coinfection, according to a study published in Hepatology.

The pangenotypic direct-acting antiviral Mavyret demonstrated 100% sustained virologic response in adolescent patients aged 12 years to 17 years with a safety profile consistent with adult patients, according results from part one of the DORA study.

Enanta Pharmaceuticals launched the first part of a phase 1a/b clinical study of EDP-514 for the treatment of hepatitis B, according to a press release.

A multistep process hemodialysis patients according to findings published in Infection Control Hospital Epidemiology.

Compared with the general U.S. population, veterans with PTSD appeared at higher risk for death by suicide, accidental injury and viral hepatitis, according to data published in American Journal of Preventive Medicine.